The impact of the SARS-CoV-2 pandemic on screening tests rates in breast and cervical cancer

Tomasz Zbigniew Zuzak; Anna Bogaczyk; Natalia Januszek; Sławomir Januszek; Tomasz Kluz

doi:10.48269/MandPH-AFMKU-23-1-001

Published: 2023-04-17

Vol. 1 No. 1 (2023)

The impact of the SARS-CoV-2 pandemic on screening tests rates in breast and cervical cancer

Tomasz Zbigniew Zuzak

, Anna Bogaczyk

, Natalia Januszek

, Sławomir Januszek

, Tomasz Kluz

Section: original research papers

https://doi.org/10.48269/MandPH-AFMKU-23-1-001

Abstract

The global SARS-CoV-2 pandemic had a significant impact on the availability of screening for breast and cervical cancer. In Poland, two pandemic waves were observed in 2020, characterized by an increase in the number of confirmed cases and deaths caused by the SARS-CoV-2 infection. This situation has reduced the number of patients registering for mammography and cytological tests. The aim of this study is to describe the problem using the available numerical data obtained from the database of the regional branch of the National Health Fund regarding the significant decrease in the number of screening tests for breast and cervical cancer in the Podkarpackie Voivodeship during the SARS-CoV-2 pandemic.

Keywords:

SARS-CoV-2 pandemic , breast cancer profilaxy , cervical cancer profilaxy , public health

Download files

PDF

Citation rules

Zuzak, Tomasz Zbigniew, et al. “The Impact of the SARS-CoV-2 Pandemic on Screening Tests Rates in Breast and Cervical Cancer”. Medicine and Public Health, vol. 1, no. 1, Apr. 2023, pp. 1-9, doi:10.48269/MandPH-AFMKU-23-1-001.

Cited by / Share